Hostname: page-component-cd9895bd7-mkpzs Total loading time: 0 Render date: 2024-12-21T01:44:55.608Z Has data issue: false hasContentIssue false

P0253 - Risk factors for partial adherence to parenteral antipsychotics in outpatients with severe mental disorders

Published online by Cambridge University Press:  16 April 2020

V. Balanza
Affiliation:
Teaching Unit of Psychiatry, University of Valencia (UVEG), Valencia, Spain CIBER Salud Mental, Instituto Carlos III, Madrid, Spain Mental Health Unit of Catarroja, Valencia, Spain
S. Cepeda
Affiliation:
Mental Health Unit of Catarroja, Valencia, Spain
L. Laguna
Affiliation:
University Hospital Doctor Peset, Valencia, Spain
J. Lerma
Affiliation:
Mental Health Unit of Catarroja, Valencia, Spain
T. Merino
Affiliation:
University Hospital Doctor Peset, Valencia, Spain
A. Tatay
Affiliation:
University Hospital Doctor Peset, Valencia, Spain
A. Pastor
Affiliation:
Mental Health Unit of Catarroja, Valencia, Spain
R. Rosales
Affiliation:
Mental Health Unit of Catarroja, Valencia, Spain
C. Knecht
Affiliation:
Mental Health Unit of Vila–real, Castello, Spain
M. Lacruz
Affiliation:
Mental Health Unit of Gandia, Valencia, Spain

Abstract

Core share and HTML view are not available for this content. However, as you have access to this content, a full PDF is available via the ‘Save PDF’ action button.
Background and Aims:

Effectiveness of parenteral antipsychotics (PAP) to prevent relapses in persons with severe mental disorders (SMD) is limited by adherence. However, data about potential risk factors for non- or partial compliance with PAP are relatively scarce and inconsistent.

Aim:

to determine variables associated with partial compliance in a naturalistic one-site study.

Methods:

The sample comprised all outpatients with SMD treated with PAP over a 12–month period at one mental health unit in Spain. Different sets of broadly– and narrowly–defined criteria for adherence were calculated from mental health nurse´s registry data. Retrospective chart review yielded sociodemographic (age, gender, educational level, civil and vocational status) and clinical (ICD–10 diagnosis, age of onset, illness duration, number of admissions, past/current substance abuse disorders, and community treatment order) variables.

Results:

Forty-nine patients were identified; most were single (83%), received a government pension (73%) and lived with their family (67%). When the strictest criteria for adherence were used, illness duration was positively associated with a > 4 day-delay in PAP injection (r=0.36; p=0.01). Furthermore, patients under community treatment orders (χ2=7.5; p=0.006) and those with past substance abuse (χ2=8.9; p=0.003) showed higher rates of non–compliance. This latter variable was the only predictor of non–compliance (exp.β=0.15; IC 95%=0.04– 0.6; p=0.007) and correctly classified 80% of the sample (χ2=8.3; R2=0.23; p=0.004).

Conclusions:

Confirming previous results, substance abuse may lead to a poorer compliance with parenteral antipsychotics. Conversely, demographic variables would play a less relevant role in adherence to PAP.

Type
Poster Session I: Neuroleptics and Antipsychotics
Copyright
Copyright © European Psychiatric Association 2008
Submit a response

Comments

No Comments have been published for this article.